<SEC-DOCUMENT>0001564590-22-018871.txt : 20220509
<SEC-HEADER>0001564590-22-018871.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509161026
ACCESSION NUMBER:		0001564590-22-018871
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33221
		FILM NUMBER:		22905018

	BUSINESS ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582514400

	MAIL ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hrtx-8k_20220509.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-04-29T23:53:53.7356721+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 1ed9e72f3e084a0d811f62fc173cf887 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:hrtx="http://www.herontx.com/20220509" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
hrtx-8k_20220509.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000818033_20220509_20220509">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000818033_20220509_20220509">0000818033</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="hrtx-20220509.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000818033_20220509_20220509">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000818033</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-09</xbrli:startDate>
					<xbrli:endDate>2022-05-09</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000818033_20220509_20220509">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000818033_20220509_20220509" format="ixt:datemonthdayyearen">May 9, 2022</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000818033_20220509_20220509">Heron Therapeutics, Inc.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000818033_20220509_20220509">001-33221</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000818033_20220509_20220509">94-2875566</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000818033_20220509_20220509">4242 Campus Point Court</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0000818033_20220509_20220509">Suite 200</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0000818033_20220509_20220509">San Diego</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0000818033_20220509_20220509">CA</ix:nonNumeric></p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0000818033_20220509_20220509">92121</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code <ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0000818033_20220509_20220509">(858)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0000818033_20220509_20220509">251-4400</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:39.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:22.6%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:34.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:39.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0000818033_20220509_20220509">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:22.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0000818033_20220509_20220509">HRTX</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:34.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">The <ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Emoji;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000818033_20220509_20220509" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Emoji;">&#9744;</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.02 Results of Operations and Financial Condition. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 9, 2022, Heron Therapeutics, Inc. (&#8220;Company&#8221;) issued a press release announcing its financial results for the three months ended March 31, 2022 (&#8220;Earnings Press Release&#8221;). A copy of the Earnings Press Release is furnished as Exhibit 99.1. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Item 2.02 and the Earnings Press Release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company&#8217;s results of operations or financial condition for the three months ended March 31, 2022, are being furnished to the Securities and Exchange Commission.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01 Financial Statements and Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="width:89%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:89%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="hrtx-ex991_6.htm"><span style="text-decoration:none;">Earnings Press Release, dated May 9, 2022</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: May 9, 2022</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Lisa Peraza</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lisa Peraza</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President, Chief Accounting Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hrtx-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
hrtx-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000001.jpg" title="" alt="" style="width:181px;height:67px;">EXHIBIT 99.1</p>
<p style="text-align:center;margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.54%;text-indent:-3.69%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">- ZYNRELEF<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> unit demand increased 68% in the first quarter compared to the prior quarter -</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.54%;text-indent:-3.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.54%;text-indent:-3.69%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">- Centers for Medicare and Medicaid Services approved a 3-year transitional pass-through status for ZYNRELEF beginning April 1, 2022 to support separate reimbursement outside of the surgical bundle payment for the HOPD setting of care -</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:8.74%;white-space:nowrap">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;letter-spacing:0pt;">-</font></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-style:italic;font-size:10pt;font-family:Arial;color:#000000;">Oncology Care Franchise net revenue of $22.4 million in Q1 2022, a </font><font style="font-size:10pt;font-family:Arial;color:#000000;">13% increase over the prior quarter </font><font style="font-style:italic;font-size:10pt;font-family:Arial;color:#000000;">-</font></p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.54%;text-indent:-3.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.54%;text-indent:-3.69%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">- Oncology Care Franchise full-year 2022 net revenue expected to be $89 million to $93 million &#8211;</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SAN DIEGO, May 9, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced financial results for the three months ended March 31, 2022 and highlighted recent corporate updates.</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Recent Corporate Updates</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Acute Care Franchise</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">ZYNRELEF:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">The ZYNRELEF (bupivacaine and meloxicam) extended-release solution New Drug Application (NDA) was approved by the U.S. Food and Drug Administration (FDA) in May 2021. In December 2021, the FDA approved our supplemental New Drug Application (sNDA) for ZYNRELEF, now covering approximately 7 million procedures annually. ZYNRELEF is currently indicated for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures. The FDA also agreed to the contents of a second sNDA, planned for later this year, designed to further expand the indication statement.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:15.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">ZYNRELEF net product sales for the three months ended March 31, 2022 were $1.1 million, which was net of $0.3 million in returns of short-dated ZYNRELEF and a continued reduction of initial distribution channel inventory. Short-dated product returns were due to delays in obtaining initial FDA approval of ZYNRELEF.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:15.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">ZYNRELEF end-user (ambulatory surgical centers (ASC) and hospitals) demand units&#8217; sales were 8,673 in the first quarter of 2022, representing an increase of 68% over the prior quarter.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:15.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">During the first three quarters of commercial launch ended March 31, 2022, over 450 unique accounts purchased ZYNRELEF with 80% of those accounts reordering the product.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">As of April 30, 2022, ZYNRELEF has received 319 formulary approvals, with over a 90% hospital approval rate, and an estimated 68% of formulary approvals have been for unrestricted use. Over 60 additional formulary review meetings are scheduled through June 30, 2022.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">Effective April 1, 2022, ZYNRELEF became the only local anesthetic separately reimbursed for Medicare patients in the Hospital Outpatient Department (HOPD) setting of care under a 3-year transitional pass-through status. Multiple commercial and Medicaid payers covering over 120 million lives have agreed to reimburse ZYNRELEF outside of the surgical bundle payment for surgeries performed in ASCs, with many of these covered lives also having their hospital outpatient procedures reimbursed outside the surgical bundle payment. Commercial and Medicaid payers represent more than 80% of our target patients in the outpatient setting. On November 2, 2021, we were issued a specific C-code (C9088) for separate reimbursement in the ASC setting of care effective January 1, 2022. </font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.65%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Courier New;text-transform:none;font-variant: normal;letter-spacing:0pt;">o</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;font-family:Arial;color:#000000;">In March 2022, Health Canada issued a Notice of Compliance to commercialize ZYNRELEF for instillation into the surgical wound for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures. Based on prior agreements with the FDA, Heron already has clinical studies underway, which we plan to submit to Health Canada to expand the indication statement. Heron is currently in partnering discussions related to Canada and other countries outside the U.S.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">NDA Submission for HTX-019 for Prevention of PONV in Adults Under Review: </font><font style="font-size:10pt;font-family:Arial;color:#000000;">A 505(b)(2) NDA for HTX-019 for the prevention of postoperative nausea and vomiting (PONV) in adults was submitted to the FDA in November 2021. The FDA accepted the NDA for filing and set a Prescription Drug User Fee Act (PDUFA) goal date of September 17, 2022.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Oncology Care Franchise</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">2022 Oncology Care Franchise Net Product Sales:</font><font style="font-size:10pt;font-family:Arial;color:#000000;"> For the three months ended March 31, 2022, oncology care franchise net product sales were $22.4&#160;million, compared to $20.0 million for the same period in 2021. During the first quarter, Heron&#8217;s oncology care franchise net product sales grew by 13% over the prior quarter with continued moderate growth expected for the remainder of 2022.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">CINVANTI<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174; </sup>Net Product Sales:</font><font style="font-size:10pt;font-family:Arial;color:#000000;"> Net product sales of CINVANTI (aprepitant) injectable emulsion for the three months ended March 31, 2022 were $20.3 million, compared to $18.5 million for the same period in 2021.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">SUSTOL</font><font style="font-size:10pt;font-family:Arial;color:#000000;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> </font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">Net Product Sales:</font><font style="font-size:10pt;font-family:Arial;color:#000000;"> Net product sales of SUSTOL (granisetron) extended-release injection for the three months ended March 31, 2022 were $2.1&#160;million, compared to $1.5 million for the same period in 2021.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;line-height:12pt;margin-left:7.77%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-size:10pt;font-family:Arial;color:#000000;">2022 Oncology Care Franchise Net Product Sales Guidance:</font><font style="font-size:10pt;font-family:Arial;color:#000000;"> Heron currently expects the second quarter of 2022 net product sales for the oncology care franchise in the range of $22 million to $23 million, with full-year 2022 net product sales for the oncology care franchise in the range of $89 million to $93 million.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Although the start of the first quarter was challenging due to the COVID-19 pandemic, in the last few months ZYNRELEF has gained momentum following the FDA approval of the expanded indications. We expect continued strong growth in the current quarter with the receipt of pass-through status from CMS for HOPD, as evidenced by an 85% increase in demand units in the first month of the second quarter versus the first month of the first quarter,&#8221; said Barry Quart, Pharm.D., Chairman and Chief Executive Officer of Heron. &#8220;In oncology care, our CINV portfolio continues to perform well and we look forward to achieving net product sales of $22 million to $23 million in the second quarter of 2022 and full year 2022 net product sales of $89 million to $93 million.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Financial Results</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net product sales for the three months ended March 31, 2022 were $23.5 million, compared to $20.0&#160;million for the same period in 2021.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron&#8217;s net loss for the three months ended March 31, 2022 was $63.9 million, or $0.63 per share, compared to $52.6 million, or $0.58 per share, for the same period in 2021. Net loss for the three months ended March 31, 2022 included non-cash, stock-based compensation expense of $10.9 million, compared to $11.5 million for the same period in 2021.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of&#160;March 31, 2022, Heron had cash, cash equivalents and short-term investments of&#160;$111.9&#160;million, compared to $157.6 million as of December 31, 2021. Net cash used for operating activities for the three months ended March 31, 2022 was $43.9 million, compared to $41.9 million for the same period in 2021. The increase in our net cash used for operating activities was primarily due to changes in working capital related to the launch of ZYNRELEF, including manufacturing of commercial inventory, and an increase in net loss. We expect net cash used for operating activities of $37 million to $39 million in the second quarter of 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Conference Call and Webcast</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk26439144"></a><a name="_Hlk26439144"></a>Heron will host a conference call and webcast on May 9, 2022 at 4:30 p.m. ET. The conference call can be accessed by dialing 1-844-825-9789 for domestic callers and 1-412-317-5180 for international callers. Please provide the operator with the passcode 10166891<font style="color:#666666;"> </font>to join the conference call. The conference call will also be available via webcast under the Investor Relations section of Heron's website at <font style="text-decoration:underline;">www.herontx.com</font>. An archive of the teleconference and webcast will also be made available on Heron&#8217;s website for 60 days following the call.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About ZYNRELEF for Postoperative Pain</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ZYNRELEF is the first and only dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of nonsteroidal anti-inflammatory drug meloxicam. ZYNRELEF is the first and only extended-release local anesthetic to demonstrate in Phase 3 studies significantly reduced pain and significantly increased proportion of patients requiring no opioids&#160;through the first 72 hours following surgery compared to bupivacaine solution, the current standard-of-care local anesthetic for postoperative pain control. ZYNRELEF was initially approved by the FDA in&#160;May 2021&#160;for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty. In December 2021, the FDA approved an expansion of ZYNRELEF&#8217;s indication. ZYNRELEF is now indicated in the U.S. in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures. Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures. In&#160;September 2020, the&#160;European Commission&#160;granted a marketing authorization for ZYNRELEF for the treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults.&#160;As of&#160;January 1, 2021, ZYNRELEF is approved in 31 European countries including the countries of the&#160;European Union&#160;and European Economic Area and the&#160;United Kingdom. In March 2022, Health Canada issued a Notice of Compliance for ZYNRELEF for instillation into the surgical wound for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please see full prescribing information, including Boxed Warning, at <font style="text-decoration:underline;">www.ZYNRELEF.com</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About HTX-019&#160;for PONV</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HTX-019 is an IV injectable emulsion formulation designed to directly deliver aprepitant, the active ingredient in EMEND<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>&#160;(aprepitant) capsules, which is the only substance P/neurokinin-1 (NK<sub style="font-size:85%; vertical-align:bottom">1</sub>) receptor antagonist (RA) to be approved in&#160;the U.S.&#160;for the prevention of PONV in adults. The&#160;FDA-approved dose of oral EMEND is 40 mg for PONV prevention, which is given within 3 hours prior to induction of anesthesia&#160;for surgery. In a Phase 1 clinical trial, 32 mg of HTX-019 as a 30-second IV injection was demonstrated to be bioequivalent to oral aprepitant 40 mg. The NDA for HTX-019 for PONV was submitted in November 2021 and the FDA set a PDUFA goal date of September 17, 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About CINVANTI for Chemotherapy Induced Nausea and Vomiting (CINV) Prevention</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CINVANTI, in combination with other antiemetic agents, is indicated in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin as a single-dose regimen, delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) as a single-dose regimen, and nausea and vomiting associated with initial and repeat courses of MEC as a 3-day regimen. CINVANTI is an IV formulation of aprepitant, an NK<sub style="font-size:85%; vertical-align:bottom">1</sub> RA. CINVANTI is the first IV formulation to directly deliver aprepitant, the active ingredient in EMEND<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>&#160;capsules. Aprepitant (including its prodrug, fosaprepitant) is the only single-agent NK<sub style="font-size:85%; vertical-align:bottom">1</sub>&#160;RA to significantly reduce nausea and vomiting in both the acute phase (0&#8211;24 hours after chemotherapy) and the delayed phase (24&#8211;120 hours after chemotherapy). The&#160;FDA-approved dosing administration included in&#160;the U.S.&#160;prescribing information for CINVANTI include 100 mg or 130 mg administered as a 30-minute IV infusion or a 2-minute IV injection.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please see full prescribing information at&#160;<font style="color:#1D4095;text-decoration:underline;">www.CINVANTI.com</font><font style="color:#1E1E1E;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About SUSTOL for CINV Prevention</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SUSTOL is indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. SUSTOL is an extended-release, injectable 5-hydroxytryptamine type 3 RA that utilizes Heron&#8217;s Biochronomer<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>&#160;drug delivery technology to maintain therapeutic levels of granisetron for &#8805;5 days. The SUSTOL global Phase 3 development program was comprised of two, large, guideline-based clinical studies that evaluated SUSTOL&#8217;s efficacy and safety in more than 2,000 patients with cancer. SUSTOL&#8217;s efficacy in preventing nausea and vomiting was evaluated in both the acute phase (0&#8211;24 hours after chemotherapy) and delayed phase (24&#8211;120 hours after chemotherapy).</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please see full prescribing information at&#160;<font style="color:#1D4095;text-decoration:underline;">www.SUSTOL.com</font><font style="color:#1E1E1E;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About&#160;Heron Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;color:#1E1E1E;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.&#160;is<font style="color:#000000;"> a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. </font>For more information, visit&#160;<font style="color:#1D4095;text-decoration:underline;">www.herontx.com</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Forward-looking Statements</p>
<p style="margin-bottom:0pt;margin-top:12pt;line-height:12pt;text-indent:0%;color:#1E1E1E;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This news release contains &#8220;forward-looking statements&#8221; as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management&#8217;s expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to, the potential additional market opportunity for the ZYNRELEF expanded U.S. label; the timing and results of studies for the further expansion of the U.S. label for ZYNRELEF; the timing of the commercial launch of ZYNRELEF in Europe and Canada; the potential market opportunities for ZYNRELEF in the U.S., Europe and Canada; the timing of the NDA review process for HTX-019 and whether the FDA approves HTX-019; the net product sales guidance for the oncology care franchise; the expected future balances of Heron&#8217;s cash, cash equivalents and short-term investments; the expected duration over which Heron&#8217;s cash, cash equivalents and short-term investments balances will fund its operations; the extent of the impact of the ongoing COVID-19 pandemic on our business; and other risks and uncertainties identified in the Company&#8217;s filings with the&#160;U.S. Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Operations</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share amounts)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues:</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net product sales</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,457</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,018</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product sales</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,355</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,207</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,070</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,116</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,533</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,573</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,422</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,236</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,380</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,132</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62,923</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,114</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(965</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(500</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(63,888</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,614</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.63</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.58</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in computing basic and diluted net</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; loss per share</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,123</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.08%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,388</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Heron Therapeutics, Inc.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Consolidated Balance Sheets</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">ASSETS</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,911</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,541</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,999</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,039</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,103</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,499</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,470</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,382</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,110</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,962</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,593</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">254,423</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,858</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,734</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use lease assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,295</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,829</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,977</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,720</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,723</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,706</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,226</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,803</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and manufacturing liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,277</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,716</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and employee liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,214</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,263</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other accrued liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,800</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,859</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current lease liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,484</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,417</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,001</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,058</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-current lease liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,391</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,996</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-current convertible notes payable, net</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,132</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,082</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other non-current liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">241</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">249,765</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">228,136</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,700,264</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,689,987</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,677,319</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,613,431</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,958</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,570</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,723</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,706</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gbkawq1hgjr3000002.jpg" title="" alt="" style="width:181px;height:71px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations and Media Contact:</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Szekeres<br />Executive Vice President, Chief Operating Officer<br />Heron Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dszekeres@herontx.com</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">858-251-4447</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gbkawq1hgjr3000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gbkawq1hgjr3000002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? C<# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@2'X>>.;;6WUV.^T%581:%>7$MK;2J^CQ1QVUL[^;YT CD:5IFE%?JO$_#O
ME7A#*.*.$,Z]CF<VZ>?\*9IF.&K9C@ZC:A[?+U[#"U:^$IU4_=:K57AZM&KS
M-TZ_+\QEN89['-\9EN;8%2PL4IY?FV%HU(8>O'=TL0G4JJG6Y9+5.$.>%2-H
M\U-/]G:\[^+GA]O%GPN^('AI1EM<\(Z[IH&,Y-UI\\?3OUZ5Z)36575D<!E=
M2K*1D,K#!!'<$$@U^5PG*G.%2.DH3C.+[2BU)?BCZ=JZ:>S33]'H?Y(?Q:T$
M>%?BG\2O"X7:/#?C_P 9:  %V@?V-XDU/3<!1@ #[+@ #@#':O/AR0/4@?F:
M^M?V\?"!\#_MC?M(:#L98_\ A;WC?5H=RE<IX@UV\UXA1_<1]2>-,<!4 ' Q
M7R4IPRD] 0?R-?ZYY'BXX_)LFQT9<\<7EF78E3VYO;X2C4;:Z.\G==.I_(>8
M4I8?'XZA))2H8S$TFELO9UIQT\K+3R/]'W_@AE\/K;P-_P $[_@S>6T$<)\:
MZ7'XMG\M0OFW&IQK+)*^ ,NY;))Y/K7Z3?&#X%?"OX]:'8>&_BQX0TSQAHVE
MZA_:EA9:I D\5M?^4T!N8A(KA9/)9H]P .UB,X)K\'?^";W_  5B_8(^"/[$
M'[.7PM^(7QPT_P />-_!WPYT?2/%&BW.EZB\NG:O;(T=S;EXH&20(57#J<,#
MD9&"?TL^#G_!5C]A7X]_$30?A5\+_C?I'B#QOXF>>/1=)-E>V7VV6WA:>6*.
MYNXHH/-$*/((]^]E1V"E4<K_ )J<8\/<8T^*N*,Z_L+B&C2AG><8W^TEEN84
MZ5.@L97FL4L4J*C&DJ5IJMSJ/)[W-;4_IO)\PRF65Y9A(X[ 3E]1P=)8?ZSA
MY2<_84E[/V7.VY*6G)RWOI8^AOA!^R9^S[\"-9U#Q#\+/AIX<\*ZUJ=O':76
MI6-A;K=&WC)(CCF$2O$&S\Y0@L."<5]&45QWQ!\>^%?A?X,\1^/O&VKV6A>%
M_"NE7FL:OJ=_<16MM;VEE \\FZ69D0.P0J@)Y8CWK\]JUL7CJZE6JU\7B:KA
M3C*K.I7K5'I"G!2DY3D]HQCKT2/?C&%*-HQC3A&[LDHQ2W;TLEW;^;.QHK^5
M_P#9T_X*O?MV_M[?MJZM\,/V6/#_ (!T;]G'0M=%UK?B_P 4^#]3O-3L?!%G
M<M%)J!U9=1MK6UUC7$5SHVF7.GS2>5$\\\JN?)C_ *F+1+B.UMH[J59[F.")
M+B=$V+-,J*)953G8)'!8+GY0<5[_ !3PCFW!V*PF SMX2EF&*P-#'U,!0Q"K
MXK 4\3%3HT<QIQBEA,7*#4Y8:4I5(1:<U'F5^#+,UPF;TJN(P/M:F&IUZE"&
M(E3<*.(E2?+.IAI-_OJ*E>*JQ7)*49*+=KEBBBBOEST@HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 >?>/OA9X"^)UOI]MXW\-Z?KJ:3?0:EILEU$OGV=[
M;.LL$]O<*!+&\4B+(FUAM=0PP1FNZMK>*TMX;6$$0P1)#&&9G(1%"J"S$LQP
M!DDDGO4]%1&E3C.=6-.$:E1152I&$5.HH7Y%.27-+DYGR\S?+=VW,XT:4*E2
MM"E3C5K*"JU8PC&I55--4U4FDI3Y%*2AS-\J;2M<_%7]OC]@/Q!X\\6Q_%/X
M.:5#=W>KH(?%'AV)EMC]O613%JMGMCEW&97G%VI12S&-_,'EA9,S]F+X0?$[
MX7?"'XW_  Z^-WPW"^!+[P1K>OVNKK;Q:CJ-M?6]K<FYL['-O'-YMP7CF@CC
M!8/$WSG<JK^WM1S0PW$4D%Q%'/!,C1RPRHLD4L;C#)(C@JZL"0RL""."*^*H
M>'O#N'XIJ\54H8JCBL4ZD<PP=&NH8'&TL1#V>+IU*#IR45B8^_-Q>E=*M%*6
M_P"<Q\+.&J'%>+XQP7UO!YECZ>)IXW"TJL7E>*6+H>QQ*KX*4&G&NU&M5A&<
M%+$159<LKW_@IUCXR3^$X+7QOX3BVW]CXLE6QMM3MRDD<=AJ,OV22]M9$#Q3
M-'%&T\+H'CEWH5#*<=OXF_;8^*W[3WC/27^-'B31H[+0='32]"CM[?\ LNQM
M(Y9X_E<^9())9"JB6<A"(U8! "V[]1?V]_\ @EGX(^'/PY^.WQTT/QAJ,4$F
MN77CC2O#2PQ+8:<]T+F]U/3HD1%_<W5]+-<([ES!E4B98U"5^$>F^%O#]Q\"
M=8UL^7)XLB^(MCI=A&%#7$E@^F6[,8T :1P+@R# R 00!D'/]A>'?T>_!+B;
MPDXVX3RW RI4>+>-Z^%PV?T<$ZV>\,X3.*V7XS)<%0JYA:G6ED%.%7!+$2YX
M3BJE?F;JIG\,<4<*<=\$8O,^%\PQ]+#91CLMS'B>IE^"Q"^I9MA\BK35%58Q
MBZ]*I-1H5*&'E.<:?/35IU832_HT\3_LJ>'#^R)X$3X.> +3XI?$_P 7?99?
M$WC/PU.M[:V<,D4DTWV:]D94>.)O*@$:?<+2'&,A?)OV8/\ @G?\5_%GQ2TP
M_%;PEJ/@_P $:+-%JNK3:@8_,U1('WPZ79I&6W^=,(_M+,ZXB4Q[761V3].O
M^"5?A+XP^#_V2? NG?%G[':(UK'+X,T2'3/[/O\ 2?#)3$"ZR6/FW&HW<PDN
MI)9$C;9*B%-R,S?I+7\?<6^"7!^"XRG2I8J6-R_A?%/*L#0PGU:&78[#Y97G
M"E7Q#IX>%3$5,1)*IBI^TE&K4YHJ<Z3O/^N,N\(>%.)H<(<48[ 8W+(X7)<F
ME#ACV>%P^#I^QH1K^QQ\8T'B<15G7GSXF=:O[2NHJ-6,>:<#.T?2=/T'2[#1
M=)M8K+3-,M8;*QM(5"16]M @2*)%   50.@]Z\]3X+?#5?B.WQ;?PQ93_$!K
M Z6OB*YW7%W#8$[OLUN)2R01[OG B5</\PYYKU.BOLIT*-14U4HTIJC.%2DI
MTXR5*I3^"=---0G#[,HV<>C1^YU,-AZJI1JT*52-"I"K052G&:I5:7\.I34D
MU"=._N2C:4?LM!1116IL%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %?&7_!0'XD>+OA)^RA\5/B!X&U'^RO$_A[3;6ZTV^V&3R7-W$CY0
M,A;<A(QO7/\ >'6OLVOSO_X*KW"VO["7QUN'^['H5LQS_P!?L-?1\'T:&(XL
MX:P^*I4ZV&KY]E-*O1JQ4Z56C4QU"%2G4@])0G!N,HO22;3W/"XGJ8BEPWG]
M7"5*E+%4\FS.>&JTI.-2G7A@ZTJ4Z<EK&<)J,HR6S29S'_!*WXW?$3X\_L]7
M'C/XE:T=<UW_ (2G6[!+HQ&';:V5_/;PIY9DEP0D2YPYSUXS@?IO7XQ?\$.;
MO[=^R')=(I$;>./%**V#M+)K%Z"-V,$C'05^SM>IXDX7"8'C[B[!X&A1PN#P
MV>X^CAL/AX*G1H4:=:484Z5.*480@E:,4K)(\W@"OC<3P3PKB,RK5L1CZ^0Y
M75QE?$2=2M5Q-3!T95JE6<M93E4<G*3W;;"BBBOB#Z\**** "BBB@#X1_P""
MD?Q3\;?!G]DSQSX_^'VJ?V-XGTK5O"5O:7^POY4&H^(;*QO0%#(2S6TT@3YU
M^?;E@,FLS_@FQ\6O'7QH_9#\+?$/XAZK_;/BK4-=\>6MQ?[&3?;:1XAO[#3E
M*LSD,EK;Q!QN8>9NP2,&N$_X+!W0L_V#OBC=,I*PZSX$9NN &\6Z8@)/898#
M)XR0.I K&_X([7B7W[ ?@2Y3[K^(_B;_ ..^+-5!S^.:_689?EO_ !!2>:/!
MX;^UEXD4\"L?[*/UM8%Y!*N\+[:W/[!UOWOL[\O/:6Y^:O%9K_Q%V."^LXK^
MQ?\ B']3$O!^T?U-YDL_ITEB'2^'ZPL,W34]^3W3\@$_:Z_;^^*/[0OQ/^%'
MP=\3?VM=Z!XJ\>M9::ML_P#H^A>'O$MWIL1,[72 F&U^Q*P$8S(SXXY/KO\
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MBC_B,%?_ *(/PZZ?\TS1Z<O_ $]_N_B'^J%/_H?<2_\ AWK>7EY?B^Y_G?\
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MM-+TNSM]/TZP@CM;.RM(EAM[:WA4)'%%&@"JJJ !QD]22237\[?_  ;LF ?
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M?M(:QG&ZN_TNHHS17YR?0GYQ_P#!6IVC_P""??[1[H<,/!<Q!]/WT=?)7_!
M21Y/V-;IW8LQ\>^*,D^VHS 5]9?\%;?^4?'[2'_8E3?^CHZ^2O\ @@!_R9G<
M_P#8_>*/_3E-_G\J_6L$_P#C2F>?]E]E?_JHJGR=:,?]=<%/E7-_J_C(\UM;
M?7<.[7[7/W4HHHK\E/K HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K\T?^"OG_*/?]H3_ +%N#_TLBK]+J_-'_@KY_P H]_VA/^Q;@_\
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MFY2IQ=HM16MHJX4445^?'OA1110 4444 %%%% !1110 4444 %%%% !1110
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M.G'VE7#TYT,?5KP<J<)RE4I4Y3A!.=K*3/5RVOC*V/PE->(N59G>K&4LOP^
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MWFMZ'H_B33+W1=>TVSU;2M0MYK2]L;Z".XM[BWN(S%-&\<BL,.C%21AAU!!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gbkawq1hgjr3000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gbkawq1hgjr3000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #2 C8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_P_"G_Z-W\9?]\VW_RRH_X@UXD_]$SB/_"O+_\ YJ\U]X?\1:\/?^BDP_\
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M>TY_8?O+\G+;K<ZO[9RW^U_[!^M4_P"U_J']J?4K2]K]0]O]6^LWY>3D]O\
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M_(W_ ,/=O^"K_P#T;59_^&*^(O\ \LZ/^'NW_!5__HVJS_\ #%?$7_Y9T?\
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M"C_HGOA/_P $UG_\;H_X4S\*/^B>^$__  36?_QNOY9_^'NW_!5__HVJS_\
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MT_3X+:?9UV[XU!Q[5_*A_P /=O\ @J__ -&U6?\ X8KXB_\ RSI1_P %=?\
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M[??V?I__ #XV?_@+#_\ $5^(W_! ;_DR"U_['WQM_P"I+JG\J_<6O4\2F_\
M7_C'5_\ )0YG_P"I50YN'%;(,E5O^99@K^OU>F4_[/T__GQL_P#P%A_^(H_L
M_3_^?&S_ / 6'_XBKE%?$<S[O[SVBG_9^G_\^-G_ . L/_Q%']GZ?_SXV?\
MX"P__$5<HHYGW?W@4_[/T_\ Y\;/_P !8?\ XBC^S]/_ .?&S_\  6'_ .(J
MY11S/N_O _''_@NG:6L/_!.SXBM%:V\3#QY\)\-'#&A&[QUI(;!50>1P?4<&
MNP_X(Y_\HX?A1_US\?\ _J2:Q7+?\%V?^4=/Q&YQ_P 5Y\)>>G_,]Z374?\
M!'+_ )1P?";WB\??^I)K%?K<G?P0H=UXF5;_ /B.TCY./_);U/\ LF:?_JRF
M?D#_ ,$8(HI?^"DO[5@EBCE 3XO$>8BOC/Q08' 8$<C@^HXK^M'^S]/_ .?&
MS_\  6'_ .(K^2[_ ((M9_X>4?M7?[GQ?_\ 5HM7];M'C6W_ *[*UU_QCW#7
M_JGPH<%JV26_ZF.:?^IU8I_V?I__ #XV?_@+#_\ $4?V?I__ #XV?_@+#_\
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MH_\ @B+_ ,F'> /^PKXB_P#3S?4__@N'_P H\_B?V_XJ'P1_Z?(JC_X(B_\
M)AOP_P#^PKXAY]?^)S?<BOM5_P F4E_V<-/_ ,P:7Z'CV_XS)/\ ZI]K_P O
MD?KQ1117Y.?4!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%VO^4='Q'_['SX2_^IWI-=3_ ,$<O^4<'PF_ZY>/O_4DUBO6O^"G?[-_CO\
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M:#Q/9:G;01/86>IWEG>VD=G(9!//+]GC_L%%>/?&7X!?!_\ :!\+77@WXO\
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MWZ;YRR1K$H6<1&,F/S9/;PW%.6XB>64IT,TP5;.,=BLOP%#,LJQV7UZN(P>
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MA"L[4IXF.'ISAAHU+-P>(G2YXIR@I13:_6>BOR-O/C[_ ,%*OA"E[XO^+_P
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M%%%>L>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^)_^"G_B6^\&?MD?L,>+-,\/7_BS4-$A\<3VOAK2@&U'5G?5_#B^1:*64&0
M9^\H Y)%?77_  V_\6?^C/\ XP_]^+/_ ./UXI^W)X5\4Z_^W!^P7XIT/0=6
MO]%T(^+FU?4;6TEDM]+_ +0U+P_);"]E0%;=GB@G?#D96%P,D8/[%5YG#N7Y
ME/BGQ+K4L9B\LHUN*LJG1_V*A.EC(PX(X4I3Q5"KBJ+=2"J4YX23HRE1C5PM
M2%U6C52Y<DP.83XBX\JT\;B<OHU<_P NE3BL)1G#$*/#&10E7IU,12DYQYH2
MH/V<G3C.E):5%,_'WXV_\%&?BSX'\$ZU>/\ LB_%+28)].N;:;Q+KT<,'AO0
MOM:K:)>:M<VYN7@@C:X,K2RQ):QI$[7$\0 #=]_P2]_9W\*?"'X8^(O'.F^+
M])\9>*?B=JD>K>);K0KR.ZTW1YFM[:4Z*OE$J)89!Y[%SO E"\+M5?T<\;Z1
M8Z_X.\4:-J6GV^JV6HZ#JMM/I]W ES;W8>RFVPR02!DDW2!2H(/S!2.0#7X>
M_P#!,WQWXD^ 7PB_:.TKQQX%\5:%:>"-3O/%^CZ6NB2M/JWVBT2RL[+2;=/^
M/J9)+%+5XHP=D8C8;D(IXO#U\OX\X=KYM5KYS0K93Q \NQU;#4Z%/AW$X>GE
MSQ<(_4L+&C6><X64N6KCJJJT/J-6GA>=8FI&FL30KX#C+(Z^:5ZV;4:N6YU]
M1Q=3#1H0R2O1A@I8E?[)1C2JO,Z&BGBI^TI?59PP_,JTXQ]]_P""G7[3O_"(
M:/X2_9F\$^*--\._$#XVZI9Z'K&OWNHKI\/@WP?>R;+_ %BYN,_NC<0I/;0!
MC&&D=?WB$<]-!\)?V-[;]D,_LI)\5OAD^D?V"N;Y?'&C1S2^-88UNXO$!NEN
M_M2R?VY&EZ9!F4'+_>)!\"_9;_8GT_\ :JO_ (@?M/\ [9?@>ZU;Q)\3-45/
M"/@CQ!+.B^#_  YID]P;$0Q*PV&YCN2R*P7R\R,J(\DF?L7_ (=?_L2?]$5T
M;_P*O/\ X[7GX3"<59[B\TXAKY%P_B\OSO!SRS*<!G^.S'!8S!\,U-*E#%8&
M.2XV%*KGDU_:&.I3E3K1HO!8'%TO:8%)<>&PO$><XK,<\JY1DV(P6;X1Y?EN
M#SG%X["8K"Y#)OGHXC"PRW$QIU,VE_MF*A.4:JIO"X:O'FPRC'P3_@EI^T=+
MX@\.^+/V8O&_B?2?$7COX)ZOJ6BZ)KUAJZ:C#XM\(V-Y-;:?=Z>Q/F20:;:P
MP6SN#(I&V0RN9!@_X+5-M_9 EX)SXU\/KQVWW*+GZ+G)]@:\N_:A_8\LOV0/
M$'PS_:>_8[^'KV-[X'UR#2OB#X.T":XGN_$?A;6]0L%OOL5DS>4\RPVK+<2,
M4PNV224*N#Z+_P %1CK7QM_8D\/ZGX+\/:OJ5_XAUWPSJ7]C6UG--J%F\@22
MYMY[=5,BM;3;H7R." 6QSCQ,YCG]/PK\0N#\WPM;$YWE'".;X? 5<&L;F$,W
MRK&9=C(Y1]6Q57#TZ^.S##JG++,;"4'C*N)PT,74IVQU%S\W,/[8I^'W&/#&
M:4)ULURKA[&TL)5PRQ.+IYCEN(PE=9=+#UZE*-7%8F@H2P&*C*/UB5;#QKSB
MUB:<I^N?#S]N.RT_P%X+L?\ A0/[0-R;/POH=J;BU^'&KRVTQ@TVVB\V"4*5
MDBD*%XW4D,K C%6?&?[;WCC4O#NH6?PR_9=^-?B#Q+?V\UA8VOB+PO/X;TV*
MYNH_(2XO+O46CC%K"9?,F(W$HI"JY^4_='PQ2XB^''@.*Z22*YB\(>'8IHI0
M1)%)%I5K&T;@\AHRNP@\@C%=S7ZU# 9O/#PA+.W3YJ,8\]'+<-"K"]-+F@ZL
MZ]-33U7/2G&^CBUH?H<,#F\\/"#SMTU*C&/-1RW#0JPO!+F@ZDZU-36ZYJ4X
MWWBUH?F7_P $[?V5O'?[.7PT^(6L_$YK.V\<?$[7-4\5:CHFF7376G:+#>6T
M12RC=HX6:17A+.7C5@&VX"@5^8W[(OQF^*GPD_:N_;$?X8_ G6_C7-K&O:<N
MJPZ-K>GZ,VA16]Y=/;R2MJ!5)Q>.\L86/+HT*D[5;G^F*_!:QO54$EK2Y  Z
MDF%P /<FOYV?V4/BVW[*O[3/[6'B/XF?#;XJSZ+\0]<LD\-W_A;P7J?B&&Y;
M3+V\EE\T6*.\2O'+&T4K 1L'(!+*P'Y[Q%DF&R"?ACEN6XO&Y5EN39SF-.69
M0ITL74PU%\,YU353&5<3A<3AH?6L35C3E6K4HP=>M&G2Y)U*<3XO/\IH9)+@
M# 8#%8O+<#E>:8^#S&,*>*J8:G+),RBZF(GB,/B,/'ZU6J<DJE6BH>TJJ-/D
MDXV^\O\ AM']K+_HPKQW_P"%SX9_^+KZ+_9W^._QB^+6JZY8_$K]GCQ#\%[7
M3+>&2QO=;UW3-775I9"Y>.!=.+",1*$RTC*2S$!<#)\7_P"'F?P=_P"B:?M
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M$_\ P60_8XL[@V5_>_$?3]14JCZ=?> M5M+Y)&8H(FM;AHK@2%P4"F(%G&T
MGBODHYGPWDLLVGB>)<;X9U\3G^8O$9;G&)RBC@,9C9XJ52IFF5/.L)B,+7P^
M=QJ4LPJ2RW$."JXBI#$4\-F2QM-?,PQN2994S*=7/L;P'7KYQCI8C+LQJY>L
M%BL3.LYRS# ?VGA*U&K1S.,H8R<L#7Y?:5IPJQI8I5XFAX8_;>_95^+'Q/\
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MOP_KLON"WE^']=E]Q7DM+2:2*6:UMY98/]1))!&\D/\ UR=E+1_\ (JQ110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hrtx-20220509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-04-29T23:53:53.7356721+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 1ed9e72f3e084a0d811f62fc173cf887 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:hrtx="http://www.herontx.com/20220509" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.herontx.com/20220509" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.herontx.com/20220509/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20220509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20220509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hrtx-20220509_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-04-29T23:53:53.7356721+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 1ed9e72f3e084a0d811f62fc173cf887 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hrtx-20220509_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-04-29T23:53:53.7356721+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 1ed9e72f3e084a0d811f62fc173cf887 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.herontx.com/20220509/role/TemplateLink" xlink:href="hrtx-20220509.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hrtx-20220509.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140633855859128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Heron Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2875566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4242 Campus Point Court<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-4400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HRTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>hrtx-8k_20220509_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hrtx-20220509.xsd" xlink:type="simple"/>
    <context id="C_0000818033_20220509_20220509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
        </entity>
        <period>
            <startDate>2022-05-09</startDate>
            <endDate>2022-05-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000818033_20220509_20220509" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000818033_20220509_20220509" id="F_000004">0000818033</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000818033_20220509_20220509" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000818033_20220509_20220509" id="F_000002">2022-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000818033_20220509_20220509" id="F_000003">Heron Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000818033_20220509_20220509" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000818033_20220509_20220509" id="F_000006">001-33221</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000818033_20220509_20220509" id="F_000008">94-2875566</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000818033_20220509_20220509" id="F_000009">4242 Campus Point Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0000818033_20220509_20220509" id="F_000010">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0000818033_20220509_20220509" id="F_000011">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000818033_20220509_20220509" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000818033_20220509_20220509" id="F_000013">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000818033_20220509_20220509" id="F_000014">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000818033_20220509_20220509" id="F_000015">251-4400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000818033_20220509_20220509" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000818033_20220509_20220509" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000818033_20220509_20220509" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000818033_20220509_20220509" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000818033_20220509_20220509" id="F_000020">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000818033_20220509_20220509" id="F_000021">HRTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000818033_20220509_20220509" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000818033_20220509_20220509" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $R!J50'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !,@:E4?!6B=>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2@,Q$(9?17+?G6R*@F&;B^*I!<&"XBTDTS:XV81D9+=O;W9MMX@^@,?,_/GF
M&YC61&E"PN<4(B9RF&]&W_59FKAF1Z(H ;(YHM>Y+HF^-/<A>4WEF0X0M?G0
M!P3!^1UX)&TU:9B 55R(3+762)-04TAGO#4+/GZF;H99 ]BAQYXR-'4#3$T3
MXVGL6K@")AAA\OF[@'8ASM4_L7,'V#DY9K>DAF&HA]6<*SLT\+;=O,SK5J[/
MI'N#Y5=VDDX1U^PR^77U\+A[8DIP(2I^6_'[G>"RX5+P]\GUA]]5V ?K]NX?
M&U\$50N_[D)] 5!+ P04    " !,@:E4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M $R!J50=W  Q6 0  /(0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9A1<^(V$,>?KY]"P_3A;H;$MH $;@@SA"1-YBXY&FBOTTX?A+V )K;E2G((
MW[XK0VQZ-6OR$"RC_?NGW=6NS'"C](M9 UCVEL2IN6JMK<T^>YX)UY (<ZXR
M2/&;I=*)L#C4*\]D&D14&"6QQWW_PDN$3%NC87%OJD=#E=M8IC#5S.1)(O3V
M&F*UN6H%K?<;SW*UMNZ&-QIF8@4SL+]E4XTCKU2)9 *ID2IE&I97K7'P^9KW
MG$$QXW<)&W-PS=Q2%DJ]N,%#=-7R'1'$$%HG(?#C%280QTX).?[9B[;*9SK#
MP^MW];MB\;B8A3 P4?%W&=GU5:O?8A$L11[;9[6YA_V""L!0Q:;XSS:[N=UN
MBX6YL2K9&R-!(M/=IWC;.^+0P#]BP/<&O.#>/:B@O!%6C(9:;9AVLU'-711+
M+:P13J8N*C.K\5N)=G9TH\(<G6R92"-VFUIIM^PAW44;O3;T+#[$3?7"O>#U
M3I ?$7P46^8/VHS[G/_7VD.TDH^7?+R0ZQR1FZA7T.RO\<)8C1'\FY#LE)*=
M0K+;M.3Y-H.Z!=+F_;,O!$2WA.B2*F,DB J*NUBLZBAH^Z6(#1 <O9*C=YHS
MIJ"E<BD0,4RD6K_02B[P@_9/'SXT1/ZB)+L@]?;)^ PKZ6*/B$\BJ>6B=>Y!
MX^Z?KT&+#'(K0]/&# _/"<3+$O'R%,0)^D^+&%4C>&-?8%L'22OY^-</^GZG
M0V#U2ZS^*5BW">B53%?L%[2W:S9122;26CA:KRG7!B77X!2N.QD#>\J3!>@Z
M%EK#]X.S3H?S@. )_*KX^:<083HHG2E=E+PVFUG< $QI]%B.D<4 JZ@V\1K4
M;VXIR(,*'9P".1=O["'"5)-+&1:DA!,;) ?=,]Z_[/4N+BC"JD8'_!3"<11I
M,+B]]A?L*\YCW])ZW]&27=[E;"*2+#=LJB3N?@R&MA1N5?\#NH*3N/.-JL6E
M)6>YQ)3!HQ %6/6&@"[N/P).W CS<:XV]1V9EIN)E-U(6"D*KFH8 5WG?X0K
M=\M4JU>9AO71IC4G8PJMZAC!22VC1)LJ8[$N_RFSXUN85ASP@"XU5:L(Z I?
MQ'",!^?C*+3 QWZO_XE"J=I#0-?SKRI$KTS7*J7J<(,([P5GW2Z=\%5C".BJ
M_EU+:R%U+2K)TWUY,[54M%!3J^)5:^!T\9ZI6(;2NO[YB FNI8CK>!I4&GFJ
M+L#IDCW5<!:B>P!WV.[TB@=(/!I_6R[KX]>@UTAV<$*G2_7_R!Z,R9&L$9"6
M;02LZCVGB_-<6CQQJ"4+^,?%)S:#,,=\JST(-2BY_,2^.[,J?&FS3&CV*N(<
MV,_^N1^P#%=KUD*3U%43X'35GFL1N>R;;9.%JL\]6N#^>?X'15)5?$Y7YW>'
ML=NW<"W2%1P]B3<(/8UG-^-?ZYB\@S=8]VO HW!'5\-B6**2?WZ)PGKW@KT;
M6)45+[4+9?$5N;A<@\!\<Q/P^Z52]GW@WI/+GSE&_P)02P,$%     @ 3(&I
M5)^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)J
MXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN
M6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9
MWMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+
ME)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64
M,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).
MIF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3
M"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^
MFO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA
M6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;
M^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.
MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( $R!J51ED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !,@:E4)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " !,@:E499!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hrtx-8k_20220509.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hrtx-8k_20220509.htm">hrtx-8k_20220509.htm</File>
    <File>hrtx-20220509.xsd</File>
    <File>hrtx-20220509_lab.xml</File>
    <File>hrtx-20220509_pre.xml</File>
    <File>hrtx-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hrtx-8k_20220509.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "hrtx-8k_20220509.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hrtx-20220509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hrtx-20220509_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hrtx-20220509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hrtx",
   "nsuri": "http://www.herontx.com/20220509",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20220509.htm",
      "contextRef": "C_0000818033_20220509_20220509",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20220509.htm",
      "contextRef": "C_0000818033_20220509_20220509",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001564590-22-018871-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-018871-xbrl.zip
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M(=,4QY7$7C]P(U[)/R25'$+Q'U<Z_Q]02P,$%     @ 3(&I5# =EGH#!0
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M>"UE>#DY,5\V+FAT;>U]:U/;2-;P]ZW:_] /,YDE5;*Q?#=D4@\!,N'9!+)
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M@<!JKK2;@3N>]C.P9SLM3.K$$N?YIU0SO(RCY#MVBH^)9(>#?6QM\/9!;P.
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M0$X70Q]@6@.==B@+T R49H7G@P;DP$9#9>2EWM3I-B;C1Z<R6G5S&\\87%F
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MAD:8(/(GOIY+&!-A4VAI<YCH&-4*)0OLA+FD?V1)5W/I2H1"]B2:&SZBD9N
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M-]JE:L,LU>OUUM:9PRX*XO;V!/&[@ZYOCU$>'PRBH0N__']02P$"% ,4
M" !,@:E48PG:\Z\$  #^%0  $0              @ $     :')T>"TR,#(R
M,#4P.2YX<V102P$"% ,4    " !,@:E4HX[B(B<'  #P2P  %0
M    @ '>!   :')T>"TR,#(R,#4P.5]L86(N>&UL4$L! A0#%     @ 3(&I
M5# =EGH#!0  %"T  !4              ( !. P  &AR='@M,C R,C U,#E?
M<')E+GAM;%!+ 0(4 Q0    ( $R!J51G7(S\+!   $F+   4
M  "  6X1  !H<G1X+3AK7S(P,C(P-3 Y+FAT;5!+ 0(4 Q0    ( $R!J51$
M$:_?RBT  '9N P 0              "  <PA  !H<G1X+65X.3DQ7S8N:'1M
64$L%!@     %  4 10$  ,1/      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
